NCT03430154View on ClinicalTrials.gov

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

CompletedOBSERVATIONAL

Enrollment

317

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

April 29, 2018

Study Completion Date

April 29, 2018

Conditions

Haemophilia A, Haemophilia B, Obesity

Interventions

OTHER

No treatment given

No treatment given

Trial Locations (1)

08536

Novo Nordisk Investigational Site, Plainsboro

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY